Securing Commercial Nucleic Acid Synthesis

20.500.12592/pc86f1k

Securing Commercial Nucleic Acid Synthesis

1 Jul 2024

On-demand gene synthesis is a growing industry that has democratized access to customized synthetic nucleic acid products used in biological research. But the increasing availability and decreasing cost of custom synthetic nucleic acids presents a risk of misuse. In this report, the authors provide recommendations for implementing comprehensive screening policies and securing commercial nucleic acid synthesis services against misuse.
biotechnology emerging technologies science and technology legislation rand-initiated science, technology, and innovation policy

Authors

Epstein, Gerald Lewis, Webster, Kyle, Roberts, Derek, Crawford, Forrest W., Nevo, Sella, Fair, Joseph

Division
RAND Global and Emerging Risks Meselson Center
Pages
74
Published in
United States
RAND Identifier
RR-A3329-1
RAND Type
report
Rights
RAND Corporation
Series
Research Reports
Source
https://www.rand.org/pubs/research_reports/RRA3329-1.html

Related Topics

All